BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25925039)

  • 21. [Molecular mechanisms of idiopathic nephrotic syndrome].
    Deschênes G; Martinat L
    Arch Pediatr; 2000 Dec; 7(12):1318-29. PubMed ID: 11147069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes.
    Nusshag C; Stütz A; Hägele S; Speer C; Kälble F; Eckert C; Brenner T; Weigand MA; Morath C; Reiser J; Zeier M; Krautkrämer E
    Sci Rep; 2020 Nov; 10(1):19117. PubMed ID: 33154421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent progress in the pathogenesis of nephrotic proteinuria.
    Tesar V; Zima T
    Crit Rev Clin Lab Sci; 2008; 45(2):139-220. PubMed ID: 18415815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A small molecule screening to detect potential therapeutic targets in human podocytes.
    Widmeier E; Tan W; Airik M; Hildebrandt F
    Am J Physiol Renal Physiol; 2017 Jan; 312(1):F157-F171. PubMed ID: 27760769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation.
    Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC
    Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of podocyte structure during the development of nephrotic syndrome.
    Smoyer WE; Mundel P
    J Mol Med (Berl); 1998 Mar; 76(3-4):172-83. PubMed ID: 9535550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.
    Li G; Kidd J; Gehr TWB; Li PL
    Cell Physiol Biochem; 2021 Apr; 55(S4):13-34. PubMed ID: 33861526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?
    Zea AH; Stewart T; Ascani J; Tate DJ; Finkel-Jimenez B; Wilk A; Reiss K; Smoyer WE; Aviles DH
    PLoS One; 2016; 11(7):e0157907. PubMed ID: 27389192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis and treatment of idiopathic nephrotic syndrome in adults].
    Sahali D; Audard V; Rémy P; Lang P
    Nephrol Ther; 2012 Jun; 8(3):180-92. PubMed ID: 22425458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.
    Li G; Kidd J; Kaspar C; Dempsey S; Bhat OM; Camus S; Ritter JK; Gehr TWB; Gulbins E; Li PL
    Am J Pathol; 2020 Jun; 190(6):1211-1223. PubMed ID: 32194052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of B7-1 in podocytes is associated with nephrotic syndrome.
    Reiser J; von Gersdorff G; Loos M; Oh J; Asanuma K; Giardino L; Rastaldi MP; Calvaresi N; Watanabe H; Schwarz K; Faul C; Kretzler M; Davidson A; Sugimoto H; Kalluri R; Sharpe AH; Kreidberg JA; Mundel P
    J Clin Invest; 2004 May; 113(10):1390-7. PubMed ID: 15146236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenetic aspectics of nephrotic syndrome].
    Walz G
    Internist (Berl); 2003 Sep; 44(9):1075-82. PubMed ID: 14566460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity.
    Burke GW; Mitrofanova A; Fontanella A; Ciancio G; Roth D; Ruiz P; Abitbol C; Chandar J; Merscher S; Fornoni A
    Front Immunol; 2023; 14():1201619. PubMed ID: 37564655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting signaling pathways in glomerular diseases.
    Henique C; Tharaux PL
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):417-27. PubMed ID: 22660552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.
    Aviles DH; Matti Vehaskari V; Manning J; Ochoa AC; Zea AH
    Kidney Int; 2004 Jul; 66(1):60-7. PubMed ID: 15200413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podocentric view of glomerular proteinuria: Focused on cytoskeletal changes and toward promising targeted therapies and challenges.
    Kuo MC; Liang PI; Chang JM
    Kaohsiung J Med Sci; 2021 Jul; 37(7):539-546. PubMed ID: 33942997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
    Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.